Unibest
← Back to patent-cliff list

CAS 5123-08-0

2-(4-chlorophenyl)-1,3,6,2-dioxazaborocane

Codes: FENOF-004

Application context (from source-drug indications)

DyslipidaemiaFenofibrate/SimvastatinHyperlipidaemiaFenofibrate/SimvastatinCardiac and vascular disordersFenofibrate/SimvastatinHypercholesterolaemiaFenofibrate/SimvastatinHypercholesterolaemiaFenofibrateHypertriglyceridaemiaFenofibrateBiliary cirrhosisFenofibrateDiabetic retinopathyFenofibrateSepsisFenofibrateType 1 diabetesFenofibrate

Source drugs (routes using this intermediate)

DrugTierExpiry
Fenofibrate/SimvastatinTier C — Watch / trade-
FenofibrateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Fenofibrate/SimvastatinOptimised routesteps: 1total yield: 149.7 mg (Fenofibrate)
2-(4-chlorophenyl)-1,3,6,2-dioxazaborocane→isopropyl 2-(4-bromophenoxy)-2-methylpropanoate
FenofibrateOptimised routesteps: 1total yield: 149.7 mg (Fenofibrate)
2-(4-chlorophenyl)-1,3,6,2-dioxazaborocane→isopropyl 2-(4-bromophenoxy)-2-methylpropanoate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.